rs17335870
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003114.5(SPAG1):c.991G>A(p.Glu331Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.197 in 1,596,798 control chromosomes in the GnomAD database, including 32,652 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_003114.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPAG1 | NM_003114.5 | c.991G>A | p.Glu331Lys | missense_variant | 10/19 | ENST00000388798.7 | NP_003105.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPAG1 | ENST00000388798.7 | c.991G>A | p.Glu331Lys | missense_variant | 10/19 | 1 | NM_003114.5 | ENSP00000373450.3 | ||
SPAG1 | ENST00000251809.4 | c.991G>A | p.Glu331Lys | missense_variant | 10/19 | 5 | ENSP00000251809.3 | |||
SPAG1 | ENST00000520508.5 | c.991G>A | p.Glu331Lys | missense_variant | 10/10 | 5 | ENSP00000428070.1 | |||
SPAG1 | ENST00000520643.5 | c.991G>A | p.Glu331Lys | missense_variant | 10/10 | 2 | ENSP00000427716.1 |
Frequencies
GnomAD3 genomes AF: 0.168 AC: 25513AN: 152040Hom.: 2462 Cov.: 33
GnomAD3 exomes AF: 0.188 AC: 45554AN: 242126Hom.: 4761 AF XY: 0.193 AC XY: 25274AN XY: 130742
GnomAD4 exome AF: 0.200 AC: 288370AN: 1444638Hom.: 30193 Cov.: 30 AF XY: 0.201 AC XY: 144427AN XY: 718100
GnomAD4 genome AF: 0.168 AC: 25508AN: 152160Hom.: 2459 Cov.: 33 AF XY: 0.169 AC XY: 12592AN XY: 74384
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 27, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Primary ciliary dyskinesia 28 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Primary ciliary dyskinesia Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 12, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at